Drug Combo for Breast Cancer Close to Getting Worldwide Approval

Building on earlier clinical trials, researchers at the University of Californina, Los Angeles have confirmed that the “breakthrough” drug palbociclib when used in combination with the traditional hormonal therapy letrozole delays progression of advanced breast cancer significantly and without the harsh side effects seen in some women prescribed letrozole alone. A release from the university… Continue reading Drug Combo for Breast Cancer Close to Getting Worldwide Approval

Breast-Cancer Drug May Help Fight Other Cancers

A new drug that’s been shown to fight breast cancer alone and in combination with endocrine therapy also combat other types of the illness, according to a University of Pennsylvania study published in JAMA Oncology. Palbociclib targets the rapid division of tumor cells by inhibiting the activity of the enzymes CDK4 and CDK6, which propel… Continue reading Breast-Cancer Drug May Help Fight Other Cancers